Boston Tech - SiliconSnark

Mustard-yellow SiliconSnark robot in Kendall Square between Prime and Beam with a gene-editing legal ruling.

Boston Tech

Prime Medicine Beat Beam in Gene-Editing Arbitration, and Cambridge Called It Family Therapy

Prime Medicine's July 8 Beam ruling cleared its AATD gene-editing program, giving Cambridge biotech one more extremely local way to compete.

SiliconSnark robot outside Vertex in Boston juggling a giant biotech deal with drug assets and deal papers.

Boston Tech

Vertex Bought Crinetics for $10 Billion, Because Boston Enjoys Expensive Homework

Vertex agreed to buy Crinetics for $10 billion on July 6, giving Boston biotech a huge endocrinology bet and a fresh test beyond cystic fibrosis.

SiliconSnark robot watches Atlas deliver a match ball while Spot patrols at a World Cup stadium.

Boston Tech

Boston Dynamics Put Atlas on the World Cup Stage, Because Waltham Never Does Anything Casually

Boston Dynamics put Atlas and Spot into FIFA World Cup 2026 operations, giving Waltham robotics its biggest global stage yet.

SiliconSnark robot outside Vertex in Boston presenting a glowing CRISPR plan beside a pediatric treatment wagon.

Boston Tech

Vertex Expanded Casgevy to Age 2, and Boston's CRISPR Future Now Comes in Toddler Sizes

Vertex's July 1 FDA expansion makes Casgevy available to children ages 2 and up, a major Boston biotech milestone with real access hurdles.

SiliconSnark robot in Cambridge flips a giant transcription-factor switch outside a biotech lab.

Boston Tech

Flare Therapeutics Raised $85 Million to Drug Transcription Factors, Which Is Extremely Cambridge

Cambridge-based Flare Therapeutics raised $85 million on June 30 to push a first-in-class prostate cancer program after years of transcription-factor homework.

SiliconSnark robot rolls a glowing drug-application binder outside a Waltham biotech campus.

Boston Tech

Cogent Filed Its Third Bezuclastinib NDA, and Waltham Looks Weirdly Inevitable

Waltham-based Cogent filed an NDA for bezuclastinib in advanced systemic mastocytosis, turning a rare-disease bet into a serious 2026 launch race.

SiliconSnark robot in Kendall Square holding an mRNA-6007 vial as giant immune cells float above Cambridge labs.

Boston Tech

Moderna Put CAR-T in a Vial, and Cambridge Called It a Platform

Cambridge-based Moderna unveiled mRNA-6007, an in vivo CAR-T bet on lupus and related autoimmune disease that could make cell therapy less bespoke.

SiliconSnark robot outside Boston Dynamics' new Waltham robotics center with Atlas, Spot, and Stretch arriving.

Boston Tech

Boston Dynamics Is Building a Bigger Waltham Robot Lair

Boston Dynamics will invest $100 million in a new Waltham robotics and AI center, adding 1,250 jobs by 2033 in a serious Massachusetts flex.

SiliconSnark robot watches a tiny MIT robot navigate a glowing HVAC maze under Cambridge using the Gleanmer chip.

Boston Tech

MIT Built a 6 Milliwatt Robot Chip Because Boston Thinks HVAC Ducts Need Homework

MIT's new Gleanmer chip maps 3D space for tiny robots at under 6 milliwatts, giving Boston robotics another deeply practical flex.

SiliconSnark robot hosts a Mass AI Coalition rooftop gathering at WHOOP in Boston.

Boston Tech

Massachusetts AI Coalition Is Building a Winning AI Flywheel in Public

A positive check-in on the Massachusetts AI Coalition, Ryan Durkin's organizing work at WHOOP, and Boston's AI momentum.

SiliconSnark robot welcomes a giant AbbVie check outside a Waltham biotech building after the Apogee deal.

Boston Tech

AbbVie Bought Apogee for $10.9 Billion Because Waltham Made Eczema Dosing Less Annoying

AbbVie is buying Waltham-based Apogee for $10.9 billion, turning a long-acting eczema antibody into Boston biotech's latest serious exit.

SiliconSnark robot routes beams of light through futuristic photonic chips in a Cambridge AI data center.

Boston Tech

HyperLight Raised $80 Million So AI Servers Can Stop Shouting Through Copper

HyperLight raised $80 million on June 18 to scale Cambridge-built photonics for AI infrastructure, turning Boston optics into a real data-center bet.

See all